Pantic M - Search Results

1

Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays.

Pfeifer D, Pantic M, Skatulla I, Rawluk J, Kreutz C, Martens UM, Fisch P, Timmer J, Veelken H. Pfeifer D, et al. Among authors: pantic m. Blood. 2007 Feb 1;109(3):1202-10. doi: 10.1182/blood-2006-07-034256. Epub 2006 Oct 19. Blood. 2007. PMID: 17053054 Free article.

2

Selective cytotoxicity and telomere damage in leukemia cells using the telomerase inhibitor BIBR1532.

El-Daly H, Kull M, Zimmermann S, Pantic M, Waller CF, Martens UM. El-Daly H, et al. Among authors: pantic m. Blood. 2005 Feb 15;105(4):1742-9. doi: 10.1182/blood-2003-12-4322. Epub 2004 Oct 26. Blood. 2005. PMID: 15507522 Free article.

3

Proteomic profiling of tumor cells after induction of telomere dysfunction.

Zimmermann S, Biniossek ML, Pantic M, Pfeifer D, Veelken H, Martens UM. Zimmermann S, et al. Among authors: pantic m. Proteomics. 2009 Feb;9(3):521-34. doi: 10.1002/pmic.200800471. Proteomics. 2009. PMID: 19132685

4

Genome-wide profiling in AML patients relapsing after allogeneic hematopoietic cell transplantation.

Waterhouse M, Pfeifer D, Pantic M, Emmerich F, Bertz H, Finke J. Waterhouse M, et al. Among authors: pantic m. Biol Blood Marrow Transplant. 2011 Oct;17(10):1450-1459.e1. doi: 10.1016/j.bbmt.2011.07.012. Epub 2011 Jul 23. Biol Blood Marrow Transplant. 2011. PMID: 21781950 Free article. Clinical Trial.

5

Tracing the development of acute myeloid leukemia in CBL syndrome.

Becker H, Yoshida K, Blagitko-Dorfs N, Claus R, Pantic M, Abdelkarim M, Niemöller C, Greil C, Hackanson B, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Döhner K, Schnittger S, Henneke P, Niemeyer CM, Flotho C, Pfeifer D, Ogawa S, Lübbert M. Becker H, et al. Among authors: pantic m. Blood. 2014 Mar 20;123(12):1883-6. doi: 10.1182/blood-2013-10-533844. Epub 2014 Feb 3. Blood. 2014. PMID: 24493670 Free article.

6

The level of telomere dysfunction determines the efficacy of telomerase-based therapeutics in a lung cancer cell line.

Pantic M, Zimmermann S, Waller CF, Martens UM. Pantic M, et al. Int J Oncol. 2005 May;26(5):1227-32. Int J Oncol. 2005. PMID: 15809713

7

Proteomic profiling in distinct cellular compartments of tumor cells reveals p53-dependent upregulation of S100A6 upon induction of telomere dysfunction.

Zimmermann S, Biniossek ML, Maurer C, Münzer P, Pantic M, Veelken H, Martens UM. Zimmermann S, et al. Among authors: pantic m. Proteomics. 2009 Nov;9(22):5175-87. doi: 10.1002/pmic.200900232. Proteomics. 2009. PMID: 19834903

8

B-cell receptor epitope recognition correlates with the clinical course of chronic lymphocytic leukemia.

Binder M, Müller F, Jackst A, Léchenne B, Pantic M, Bacher U, Zu Eulenburg C, Veelken H, Mertelsmann R, Pasqualini R, Arap W, Trepel M. Binder M, et al. Among authors: pantic m. Cancer. 2011 May 1;117(9):1891-900. doi: 10.1002/cncr.25755. Epub 2010 Nov 29. Cancer. 2011. PMID: 21509766 Free article.

9

B-cell signaling in persistent polyclonal B lymphocytosis (PPBL).

Voelxen N, Wehr C, Gutenberger S, Keller B, Erlacher M, Dominguez-Conde C, Bertele D, Emmerich F, Pantic M, Jennings S, Rakhmanov M, Foerster C, Martens UM, Platzbecker U, Peter HH, Fisch P, Boztug K, Eibel H, Salzer U, Warnatz K. Voelxen N, et al. Among authors: pantic m. Immunol Cell Biol. 2016 Oct;94(9):830-837. doi: 10.1038/icb.2016.46. Epub 2016 Apr 29. Immunol Cell Biol. 2016. PMID: 27126628

10

Telomere dysfunction and loss of p53 cooperate in defective mitotic segregation of chromosomes in cancer cells.

Pantic M, Zimmermann S, El Daly H, Opitz OG, Popp S, Boukamp P, Martens UM. Pantic M, et al. Oncogene. 2006 Jul 27;25(32):4413-20. doi: 10.1038/sj.onc.1209486. Epub 2006 Mar 20. Oncogene. 2006. PMID: 16547498

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

113 results

Search Page